SANUWAVE Health, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
SANUWAVE Health, Inc. (SNWV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value of $0.15 per share for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue · last filed 2020-03-30
- SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2018-06-30 was $0.41.
- SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2018-03-31 was $0.00.
- SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2016-06-30 was $0.05, a 90.91% decline year-over-year.
- SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2015-09-30 was $0.51, a 7.27% decline year-over-year.
- SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2019 was $0.15, a 40.00% decline from fiscal 2018.
- SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2018 was $0.25, a 127.27% increase from fiscal 2017.
- SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2017 was $0.11, a 0.00% change from fiscal 2016.
- SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2016 was $0.11, a 69.44% decline from fiscal 2015.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|
| 2019-12-31 | $0.15 10-K · filed 2020-03-30 | |
| 2018-12-31 | $0.25 10-K · filed 2020-03-30 | |
| 2018-06-30 | $0.41 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-08-14 | |
| 2017-12-31 | $0.11 10-K · filed 2019-04-01 | |
| 2016-12-31 | $0.11 10-K · filed 2018-03-29 | |
| 2016-06-30 | $0.05 10-Q · filed 2016-11-08 | |
| 2015-12-31 | $0.36 10-K · filed 2017-03-31 | |
| 2015-09-30 | $0.51 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $0.55 10-Q · filed 2015-11-12 | |
| 2015-03-31 | $0.35 10-Q · filed 2015-11-12 | |
| 2014-12-31 | $0.41 10-K · filed 2016-03-30 | |
| 2014-09-30 | $0.55 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $0.55 10-Q · filed 2014-11-12 | |
| 2014-03-31 | $0.35 10-Q · filed 2014-11-12 | |
| 2013-12-31 | $0.39 10-K · filed 2015-03-03 | |
| 2012-12-31 | $1.52 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |